Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol
  • Published:

Synthesis of N-succinimidyl 4-[18F]fluorobenzoate, an agent for labeling proteins and peptides with 18F

Abstract

This protocol describes the step-by-step procedure for the synthesis of N-succinimidyl 4-[18F]fluorobenzoate ([18F]SFB), an agent widely used for labeling proteins and peptides with the positron-emitting radionuclide 18F. The protocols for the synthesis of unlabeled SFB and the quaternary salt precursor 4-formyl-N,N,N-trimethyl benzenaminium trifluoromethane sulfonate also are described. For the [18F]SFB synthesis, the quaternary salt is first converted to 4-[18F]fluorobenzaldehyde. Oxidation of the latter provides 4-[18F]fluorobenzoic acid, which is converted to [18F]SFB by treatment with N,N-disuccinimidyl carbonate. Using this method, [18F]SFB can be synthesized in decay-corrected radiochemical yields of 30%–35% and a specific radioactivity of 11–12 GBq μmol−1. The total synthesis and purification time required is about 80 min, starting from delivery of the [18F]fluoride. [18F]SFB remains an optimal reagent for labeling proteins and peptides with 18F because of good conjugation yields and metabolic stability.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Scheme for the synthesis of N-succinimidyl 4-[18F]fluorobenzoate.
Figure 2

Similar content being viewed by others

References

  1. Kelloff, G.J. et al. The progress and promise of molecular imaging probes in oncologic drug development. Clin. Cancer Res. 11, 7967–7985 (2005).

    CAS  PubMed  Google Scholar 

  2. Weissleder, R. Molecular imaging in cancer. Science 312, 1168–1171 (2006).

    CAS  PubMed  Google Scholar 

  3. Rohren, E.M., Turkington, T.G. & Coleman, R.E. Clinical applications of PET in oncology. Radiology 231, 305–332 (2004).

    PubMed  Google Scholar 

  4. Okarvi, S.M. Recent progress in fluorine-18 labelled peptide radiopharmaceuticals. Eur. J. Nucl. Med. 28, 929–938 (2001).

    CAS  PubMed  Google Scholar 

  5. Wilbur, D.S. Radiohalogenation of proteins: an overview of radionuclides, labeling methods, and reagents for conjugate labeling. Bioconjug. Chem. 3, 433–470 (1992).

    CAS  PubMed  Google Scholar 

  6. Chang, Y.S. et al. Preparation of 18F-human serum albumin: a simple and efficient protein labeling method with 18F using a hydrazone-formation method. Bioconjug. Chem. 16, 1329–1333 (2005).

    CAS  PubMed  Google Scholar 

  7. de Bruin, B. et al. 1-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione: design, synthesis, and radiosynthesis of a new [18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins. Bioconjug. Chem. 16, 406–420 (2005).

    CAS  PubMed  Google Scholar 

  8. Garg, P.K., Garg, S. & Zalutsky, M.R. Fluorine-18 labeling of monoclonal antibodies and fragments with preservation of immunoreactivity. Bioconjug. Chem. 2, 44–49 (1991).

    CAS  PubMed  Google Scholar 

  9. Glaser, M. et al. 18F-fluorothiols: a new approach to label peptides chemoselectively as potential tracers for positron emission tomography. Bioconjug. Chem. 15, 1447–1453 (2004).

    CAS  PubMed  Google Scholar 

  10. Kilbourn, M.R., Dence, C.S., Welch, M.J. & Mathias, C.J. Fluorine-18 labeling of proteins. J. Nucl. Med. 28, 462–470 (1987).

    CAS  PubMed  Google Scholar 

  11. Shai, Y. et al. 18F-labeled insulin: a prosthetic group methodology for incorporation of a positron emitter into peptides and proteins. Biochemistry 28, 4801–4806 (1989).

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Toyokuni, T. et al. Synthesis of a new heterobifunctional linker, N-[4-(aminooxy)butyl]maleimide, for facile access to a thiol-reactive 18F-labeling agent. Bioconjug. Chem. 14, 1253–1259 (2003).

    CAS  PubMed  Google Scholar 

  13. Wust, F., Muller, M. & Bergmann, R. Synthesis of 4-([F-18]fluoromethyl)-2-chlorophenylisothiocyanate: A novel bifunctional F-18-labelling agent. Radiochimica Acta 92, 349–353 (2004).

    Google Scholar 

  14. Vaidyanathan, G. & Zalutsky, M.R. Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F]fluorobenzoate. Appl. Radiat. Isot. 19, 275–281 (1992).

    CAS  Google Scholar 

  15. Vaidyanathan, G. & Zalutsky, M.R. Improved synthesis of N-succinimidyl 4-[18F]fluorobenzoate and its application to the labeling of a monoclonal antibody fragment. Bioconjug. Chem. 5, 352–356 (1994).

    CAS  PubMed  Google Scholar 

  16. Vaidyanathan, G. & Zalutsky, M.R. Preparation of N-succinimidyl 3-[*I]iodobenzoate: an agent for the indirect radioiodination of proteins. Nat. Protocols 1, 707–713 (2006).

    CAS  PubMed  Google Scholar 

  17. Vaidyanathan, G. & Zalutsky, M.R. Fluorine-18-labeled [Nle4,D-Phe7]-α-MSH, an α-melanocyte stimulating hormone analogue. Nucl. Med. Biol. 24, 171–178 (1997).

    CAS  PubMed  Google Scholar 

  18. Vaidyanathan, G. & Zalutsky, M.R. Fluorine-18 labeled chemotactic peptides: a potential approach for the PET imaging of bacterial infection. Nucl. Med. Biol. 22, 759–764 (1995).

    CAS  PubMed  Google Scholar 

  19. Page, R.L., Garg, P.K., Vaidyanathan, G. & Zalutsky, M.R. Preclinical evaluation and PET imaging of 18F-labeled Mel-14 F(ab')2 fragment in normal dogs. Nucl. Med. Biol. 21, 911–919 (1994).

    CAS  PubMed  Google Scholar 

  20. Vaidyanathan, G., Bigner, D.D. & Zalutsky, M.R. Fluorine-18-labeled monoclonal antibody fragments: a potential approach for combining radioimmunoscintigraphy and positron emission tomography. J. Nucl. Med. 33, 1535–1541 (1992).

    CAS  PubMed  Google Scholar 

  21. Wester, H.J., Hamacher, K. & Stocklin, G. A comparative study of N.C.A. fluorine-18 labeling of proteins via acylation and photochemical conjugation. Nucl. Med. Biol. 23, 365–372 (1996).

    CAS  PubMed  Google Scholar 

  22. Azarian, V. et al. Synthesis and liposome encapsulation of a novel 18F-conjugate of ω-conotoxin GVIA for the potential imaging of N-type Ca2+ channels in the brain by positron emission tomography. J. Labelled Comp. Radiopharm. 49, 269–283 (2006).

    CAS  Google Scholar 

  23. Chen, X. et al. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl. Med. Biol. 31, 179–189 (2004).

    CAS  PubMed  Google Scholar 

  24. Grierson, J.R. et al. Production of [F-18]fluoroannexin for imaging apoptosis with PET. Bioconjug. Chem. 15, 373–379 (2004).

    CAS  PubMed  Google Scholar 

  25. Guenther, K.J. et al. Synthesis and in vitro evaluation of 18F- and 19F-labeled insulin: a new radiotracer for PET-based molecular imaging studies. J. Med. Chem. 49, 1466–1474 (2006).

    CAS  PubMed  Google Scholar 

  26. Kiesewetter, D.O. et al. Fluoro-, bromo-, and iodopaclitaxel derivatives: synthesis and biological evaluation. Nucl. Med. Biol. 30, 11–24 (2003).

    CAS  PubMed  Google Scholar 

  27. Lang, L. et al. Development of fluorine-18-labeled 5–HT1A antagonists. J. Med. Chem. 42, 1576–1586 (1999).

    CAS  PubMed  Google Scholar 

  28. Zhang, X. et al. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. J. Nucl. Med. 47, 492–501 (2006).

    CAS  PubMed  Google Scholar 

  29. Haka, M.S., Kilbourn, M.R., Watkins, G.L. & Toorongian, S.A. Aryltrimethylammonium trifluoromethanesulfonates as precursors to aryl [18F]fluorides: improved synthesis of [18F]GBR-13119. J. Labelled Comp. Radiopharm. 27, 823–833 (1989).

    CAS  Google Scholar 

  30. Pascali, G., Kiesewetter, D.O., Salvadori, P.A. & Eckelman, W.C. Use of 1,8-bis-(dimethylamino)naphthalene/H18F complex as a new fluorinating agent. J. Labelled Comp. Radiopharm. 47, 373–383 (2004).

    CAS  Google Scholar 

  31. Mading, P., Fuchtner, F. & Wust, F. Module-assisted synthesis of the bifunctional labelling agent N-succinimidyl 4-[18F]fluorobenzoate ([18F]SFB). Appl. Radiat. Isot. 63, 329–332 (2005).

    CAS  PubMed  Google Scholar 

  32. Wust, F., Hultsch, C., Bergmann, R., Johannsen, B. & Henle, T. Radiolabelling of isopeptide N epsilon-(gamma-glutamyl)-L-lysine by conjugation with N-succinimidyl-4-[18F]fluorobenzoate. Appl. Radiat. Isot. 59, 43–48 (2003).

    CAS  PubMed  Google Scholar 

  33. Zijlstra, S., Gunawan, J., Freytag, C. & Burchert, W. Synthesis and evaluation of fluorine-18 labelled compounds for imaging of bacterial infections with PET. Appl. Radiat. Isot. 64, 802–807 (2006).

    CAS  PubMed  Google Scholar 

  34. Zijlstra, S., Gunawan, J. & Burchert, W. Synthesis and evaluation of a 18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET. Appl. Radiat. Isot. 58, 201–207 (2003).

    CAS  PubMed  Google Scholar 

  35. Kilbourn, M.R. in Fluorine-18 Labeling of Radiopharmaceuticals 41–42 (National Academy Press, Washington, D.C., 1990).

  36. Schlyer, D.J., Firouzbakht, M.L. & Wolf, A.P. Impurities in the [18O]water target and their effect on the yield of an aromatic displacement reaction with [18F]fluoride. Appl. Radiat. Isot. 44, 1459–1465 (1993).

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from US Department of Energy and the US National Institutes of Health.

Author information

Authors and Affiliations

Authors

Contributions

G.V. conceived the idea, designed and executed the experiments and contributed to the writing of the paper. M.R.Z. provided financial support and contributed to the writing of the paper.

Corresponding authors

Correspondence to Ganesan Vaidyanathan or Michael R Zalutsky.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vaidyanathan, G., Zalutsky, M. Synthesis of N-succinimidyl 4-[18F]fluorobenzoate, an agent for labeling proteins and peptides with 18F. Nat Protoc 1, 1655–1661 (2006). https://doi.org/10.1038/nprot.2006.264

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nprot.2006.264

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing